BridgeMD
New treatment option for Plasmodium Falciparum Malaria
Official title Mass Vaccine and Drug Administration, Bangladesh
ClinicalTrials.gov ID: NCT06068530
What this study is testing
What is DHA/piperaquine and a SLD-PQ?
DHA/piperaquine and a SLD-PQ is an investigational medicine, given as an once-daily pill taken by mouth, being studied as a potential treatment for plasmodium falciparum malaria.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This is an open i.e. not blinded, cluster-randomised, controlled intervention study.
- Phase 4: studies an already-approved treatment
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 6 and older
You may be able to join if
- Current residence in a study village irrespective of permanence
- Age 6 months and above (no upper age limit)
- Written informed consent provided by participants (or a parent/guardian in case the participant is under 18 years old)
You likely can't join if
- Pregnancy, plan to get pregnant, or breastfeeding.
- Acute illness requiring intervention
- A history of an adverse reaction to study drugs/vaccine and prior receipt of any other malaria vaccine or enrolment in another intervention trial.
The study team makes the final eligibility decision.
Where it's taking place
- Bāndarban, Bangladesh
- Lāma, Bangladesh
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 6 months and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bāndarban, Bangladesh; Lāma, Bangladesh. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.